Discover 137 paid clinical trials in Shreveport, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 137
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Shreveport LA, Tyler TX, Jackson MS, Austin TX,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase 2, Recruiting
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
for
Malignant Neoplasm
Location: Shreveport LA, Houston TX, San Antonio TX, Hastings NE,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06979596
Phase 2, Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: Shreveport LA, Tyler TX, Fort Worth TX, Jackson MS,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase 3, Recruiting
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).
for
Ovarian Cancer Recurrent
Location: Shreveport LA, Fort Worth TX, Oklahoma City OK,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06843447
Phase 1, Phase 2, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Shreveport LA, Nashville TN, Indianapolis IN,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Shreveport LA, Tyler TX, West Monroe LA, Greenville TX,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
for
Endometrial Adenocarcinoma
Location: Shreveport LA, Little Rock AR, Houston TX,
Sponsor: Acrivon Therapeutics
Sex: Female
Age: 18+
Code: NCT05548296
Phase 2, Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
for
Heart Failure
Location: Bossier City LA, Shreveport LA, Longview TX,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06424288
Phase 3, Recruiting
Next Generation Sequencing Versus Traditional Cultures for Clinically Infected Penile Implants: Impact of Culture Identification on Outcomes
for
Penile Implantation, Infections
Location: Bossier City LA, Raleigh NC, Philadelphia PA
Sponsor: MicroGenDX
Sex: Male
Age: 18 - 70+
Code: NCT05287438
Recruiting
Water Vapor Ablation for Prostate Cancer: Long-Term Registry
for
Prostate Cancer
Location: Bossier City LA, San Antonio TX, Woodbury MN,
Sponsor: Francis Medical Inc.
Sex: Male
Age: 0+
Code: NCT07455058
Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)
for
Complicated Intra-abdominal Infections (cIAI)
Location: Shreveport LA, Chicago IL, Morgantown WV, Orange CA,
Sponsor: Tetraphase Pharmaceuticals, Inc
Sex: All
Age: 8 - 17
Code: NCT06794541
Phase 2, Recruiting
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Shreveport LA, Houston TX, Birmingham AL, Atlanta GA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06615479
Phase 3, Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma